Pressure Gradient vs. Flow Relationships in Patients With Symptomatic Valvular Aortic Stenosis
PREFLOW
1 other identifier
observational
26
1 country
1
Brief Summary
The objective of the present study is to investigate to hemodynamic profile at rest and during peak exercise of patients with suspected severe aortic stenosis and to compare flow- and pressure changes between high gradient patients and low gradient patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedFirst Submitted
Initial submission to the registry
May 10, 2022
CompletedFirst Posted
Study publicly available on registry
October 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedJanuary 3, 2024
January 1, 2024
4.3 years
May 10, 2022
January 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Pressure and flow relationships across the aortic valve during rest and during supine exercise
Pressure drop across the aortic valve measured invasively. Flow across the valve estimated by right heart catheterization in the absence of aortic valve regurgitation.
2 hours
Study Arms (1)
Severe aortic valve stenosis
Interventions
Pressure recordings across the aortic valve with simultaneous flow measurements by right heart catheterization, during rest and during supine exercise.
Eligibility Criteria
Patients with suspected severe AS scheduled for evaluation for aortic valve intervention
You may qualify if:
- Patients with suspected severe AS scheduled for evaluation for aortic valve intervention:
- LVEF \> 50 %
- AVA \< 1.0 cm2
- Symptomatic - at least equivalent to NYHA functional class II
You may not qualify if:
- Congenital heart disease
- Severe coronary artery disease (main stem, proximal LAD or 3 vessel disease)
- Moderate or severe aortic valve regurgitation
- Moderate or severe mitral valve regurgitation or stenosis
- Moderate or severe pulmonary valve regurgitation or stenosis
- Moderate or severe tricuspid valve regurgitation or stenosis
- Severe pulmonary hypertension (tricuspid valve pressure gradient of 60 mmHg)
- Right ventricular dysfunction (TAPSE \< 17 mm)
- Restrictive cardiomyopathy or cardiac amyloidosis
- Constrictive pericarditis
- Inability to perform supine bicycle exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aarhus University Hospital
Aarhus, 8200, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Henrik Vase, MD, PhD
Department of Cardiology, Aarhus University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Specialist, MD, PhD
Study Record Dates
First Submitted
May 10, 2022
First Posted
October 14, 2022
Study Start
September 1, 2019
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
January 3, 2024
Record last verified: 2024-01